| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |